LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Saroglitazar Mg is an investigational compound in the USA/EU, undergoing Phase 2b/3 clinical trials in patients with Primary Biliary Cholangitis and Phase 2b in patients with Non- alcoholic Steatohepatitis
Approval based on HIMALAYA Phase III trial results which showed single priming dose of Imjudo added to Imfinzi reduced risk of death by 22% vs. sorafenib
ELCYS is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to amino acid solutions
An algorithm based testing for Fatty Liver Disease
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.
Subscribe To Our Newsletter & Stay Updated